Here are three high-impact areas where therapy providers could consider deploying AI to maximize their return on investment.
She reminds him, if he lies to her, Xander is breaking the conditions of his therapy (Again, not cool, Doctor Evans). Xander ...
APOLLO is a multimodal temporal foundation model trained on 25.2 billion medical events from 7.2 million patients across 33 ...
Alnylam Pharmaceuticals, Inc. is rated a Hold due to intense ATTR-CM competition and pipeline execution risks. Read more on ...
These expert tips for avoiding beginner runner mistakes will help you avoid the pitfalls along your path to consistency and a ...
Kyverna Therapeutics has unveiled the full results from its registrational trial of miv-cel in stiff person syndrome (SPS), ...
Payers and providers have long eyed each other with suspicion, but a growing cohort of health system leaders say that ...
A 2026 informational overview of Moonbird's tactile breathing coach technology, EEG brain scan research references, real-time ...
New East Valley location brings additional treatment capacity closer to local families.United States, April 25, 2026 -- ...
After President Donald Trump signed an executive order (1) aimed at fast-tracking research and access to psychedelic ...
Cue Biopharma, Inc. ( CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases April 7, 2026 10:00 AM EDT Lucinda Warren - Interim CEO, Interim President,Principal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results